Latest News & Updates

Latest Articles
Atezolizumab Approaches EU Approval for NSCLC, Urothelial Carcinoma
The European Medicines Agency’s Committee for Medicinal Products for Human Use has taken a positive position on indications for atezolizumab in non­-small cell lung cancer and urothelial carcinoma.
PUBLISHED: July 21, 2017
Frontline Obinutuzumab Recommended for EU Approval for Follicular Lymphoma
The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of obinutuzumab in the frontline setting for the treatment of patients with follicular lymphoma.
PUBLISHED: July 21, 2017
EMA Panel Backs Approval of Lutathera for GEP-NETs
The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of Lutathera for the treatment of patients with unresectable or metastatic, progressive, well-differentiated, somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors.
PUBLISHED: July 21, 2017
Novel Therapeutic Strategies for Metastatic TNBC
Joyce O'Shaughnessy, MD, provides an update on existing research and a look at the future of novel therapeutic strategies for metastatic triple-negative breast cancer.
PUBLISHED: July 21, 2017
Avelumab Recommended for EU Approval for Merkel Cell Carcinoma
The European Medicines Agency's Committee for Medicinal Products for Human Usehas recommended approval of avelumab (Bavencio) for adults with metastatic Merkel cell carcinoma, according to Pfizer and Merck, the codevelopers of the PD-L1 inhibitor.
PUBLISHED: July 21, 2017
Latest Peer Exchange Discussions
MDS: The Current Understanding in Molecular Testing and Biomarkers
Panelists James M. Foran, MD, FRCPC, and Azra Raza, MD, provide insight on the current understanding in molecular testing and biomarkers in myelodysplastic syndrome. View Now
ALK-Positive Lung Cancer
Panelists Mark A. Socinski, MD; Gregory J. Riely, MD, PhD; Jared Weiss, MD; Thomas E. Stinchcombe, MD; and Benjamin P. Levy, MD; provide insight on the treatment options in ALK-positive lung cancer. View Now
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment and Management of CINVJul 26, 20171.5
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Genitourinary CancersJul 28, 20171.5
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 29, 20171.5
Advances in™ Precision Medicine: The Evolving Role of Genomics and Proteomics in Cancer TreatmentJul 29, 20171.5
Publication Bottom Border
Border Publication